V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017333 | 220017803 | 1.56 | 82 | Curative (C) | 2017-03-25 | 2017-04-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030085 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017334 | 220007822 | 0 | 69.7 | Curative (C) | 2018-04-09 | 2018-04-11 | Dasatinib | 02 | N | 220030087 | DASATINIB |
| 220017335 | 220017804 | null | 81.1 | Curative (C) | 2017-04-17 | 2017-04-26 | AML 18 TRIAL | N | N | 220030089 | AML18 TRIAL |
| 220017336 | 220014305 | 1.86 | 80 | Curative (C) | 2017-03-27 | 2017-03-28 | AML 18 TRIAL | 01 | N | 220030092 | AML18 TRIAL |
| 220017337 | 220014305 | 1.59 | 62 | null | 2016-06-23 | 2016-06-28 | AML 18 TRIAL | Y | N | 220030092 | AML18 TRIAL |
| 220017338 | 220007824 | 1.72 | 90 | Curative (C) | 2013-10-09 | 2013-10-18 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030093 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017339 | 220014307 | 1.5 | 0 | Curative (C) | 2017-08-18 | 2017-11-07 | Rituximab | N | N | 220030106 | RITUXIMAB |
| 220017340 | 220014308 | 1.85 | 96.6 | Curative (C) | null | 2014-03-15 | Alemtuz+Fludara+Melphalan RIC MUD | Y | N | 220030109 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017341 | 220014309 | 0 | 80 | Curative (C) | 2015-12-12 | 2015-12-12 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220030109 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017342 | 220007830 | 1.85 | 72 | Disease modification (D) | 2015-11-03 | 2015-11-09 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220030114 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017343 | 220021891 | 1.71 | 42.35 | Curative (C) | 2018-10-05 | 2019-02-13 | Dasatinib | N | N | 220030117 | DASATINIB |
| 220017344 | 220021891 | 1.7 | 42.35 | Curative (C) | 2019-03-06 | 2019-03-06 | Dasatinib | 2 | N | 220030117 | DASATINIB |
| 220017345 | 220014311 | 1.6 | 93 | Disease modification (D) | 2013-10-12 | 2014-03-07 | AML18 PILOT TRIAL | 1 | N | 220030138 | PILOT TRIAL |
| 220017346 | 220014313 | 1.67 | null | Adjuvant (A) | 2017-12-05 | 2017-12-19 | Dasatinib | N | N | 220030141 | DASATINIB |
| 220017347 | 220007835 | 1.96 | null | Curative (C) | 2015-07-11 | 2015-08-23 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030142 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017348 | 220007838 | null | 63.9 | Curative (C) | 2015-11-24 | 2015-11-24 | AML18 PILOT TRIAL | N | null | 220030144 | PILOT TRIAL |
| 220017349 | 220007841 | 1.64 | 72 | Curative (C) | null | 2014-01-24 | AML 18 TRIAL | 01 | null | 220030145 | AML18 TRIAL |
| 220017350 | 220007844 | 1.67 | null | Curative (C) | 2018-01-21 | 2018-02-06 | Dasatinib | N | N | 220030148 | DASATINIB |
| 220017351 | 220007851 | 1.86 | 89.3 | Curative (C) | 2019-01-24 | 2019-01-24 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220030168 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017352 | 220007853 | 1.5 | 66.4 | Palliative (P) | 2015-07-29 | 2015-07-29 | AML 18 TRIAL | Y | N | 220030168 | AML18 TRIAL |
| 220017353 | 220007854 | 1.71 | 64.8 | Curative (C) | 2014-12-02 | 2014-12-02 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220030179 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017354 | 220007856 | 1.56 | 68.9 | Neo-adjuvant (N) | 2016-10-12 | 2016-10-19 | Dasatinib | N | N | 220030182 | DASATINIB |
| 220017355 | 220007860 | 1.72 | null | Curative (C) | 2015-01-20 | 2017-12-25 | Rituximab | N | N | 220030188 | RITUXIMAB |
| 220017356 | 220007864 | 0 | 63.5 | Curative (C) | 2017-07-30 | 2017-08-05 | Dasatinib | 1 | null | 220030191 | DASATINIB |
| 220017357 | 220007870 | 1.78 | 109 | Curative (C) | 2013-07-20 | 2013-07-26 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030214 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017358 | 220007873 | 1.76 | 77.7 | Curative (C) | 2017-03-31 | 2017-03-31 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030225 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017359 | 220007877 | 1.65 | 108 | Curative (C) | 2017-09-28 | 2017-10-01 | AML 18 TRIAL | N | N | 220030228 | AML18 TRIAL |
| 220017360 | 220007878 | 1.78 | 77.5 | Curative (C) | 2016-10-31 | 2017-02-04 | AML 18 TRIAL | Y | N | 220030233 | AML18 TRIAL |
| 220017361 | 220007883 | null | 115 | Disease modification (D) | 2013-05-08 | 2013-05-12 | Dasatinib | 2 | null | 220030238 | DASATINIB |
| 220017362 | 220007884 | null | 76.9 | Curative (C) | 2014-01-09 | 2015-11-25 | Dasatinib | N | null | 220030250 | DASATINIB |
| 220017365 | 220007892 | 1.57 | 40.3 | Curative (C) | 2017-04-26 | 2017-04-26 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030275 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017366 | 220007895 | 1.71 | 77 | Curative (C) | 2017-12-19 | 2017-12-19 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030276 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017367 | 220007897 | 1.85 | 80.9 | Disease modification (D) | 2013-10-22 | 2014-01-22 | AML18 PILOT TRIAL | 1 | N | 220030281 | PILOT TRIAL |
| 220017368 | 220007899 | 0 | 73.6 | Curative (C) | 2013-09-18 | 2013-09-25 | Rituximab | 02 | N | 220030289 | RITUXIMAB |
| 220017369 | 220007901 | 1.64 | 68.4 | Disease modification (D) | 2014-09-05 | 2014-09-13 | AML 18 TRIAL | Y | N | 220030292 | AML18 TRIAL |
| 220017370 | 220007902 | 1.93 | 65.2 | Disease modification (D) | 2016-06-20 | 2016-06-20 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220030293 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017371 | 220014336 | 1.6 | 72.2 | Disease modification (D) | 2014-10-08 | 2014-10-13 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030293 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017372 | 220007905 | 1.66 | 51.5 | Curative (C) | 2016-12-06 | 2017-04-02 | AML18 PILOT TRIAL | Y | N | 220030299 | PILOT TRIAL |
| 220017373 | 220007908 | 1.62 | 71.45 | Palliative (P) | 2014-05-31 | 2014-06-01 | AML 18 TRIAL | Y | N | 220030302 | AML18 TRIAL |
| 220017374 | 220014341 | 1.8 | 104 | Disease modification (D) | 2017-02-27 | 2017-03-02 | AML18 PILOT TRIAL | null | null | 220030310 | PILOT TRIAL |
| 220017375 | 220014344 | 1.66 | 101.5 | Curative (C) | 2015-03-19 | 2015-03-19 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030316 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017376 | 220014345 | 1.7 | 52 | Curative (C) | 2017-07-26 | 2017-08-01 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030318 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017377 | 220019778 | 0 | 77.7 | Disease modification (D) | 2015-04-21 | 2015-04-21 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030337 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017378 | 220007926 | 1.6 | 66.8 | Curative (C) | 2013-12-15 | 2013-12-27 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030339 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017379 | 220007927 | null | 27.5 | Disease modification (D) | 2016-02-25 | 2016-04-28 | Rituximab | N | N | 220030348 | RITUXIMAB |
| 220017380 | 220007928 | 1.6 | 57.2 | Curative (C) | 2013-11-23 | 2013-11-23 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030353 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017381 | 220014350 | 1.7 | 72 | Curative (C) | 2014-06-22 | 2014-06-27 | Rituximab | N | N | 220030353 | RITUXIMAB |
| 220017382 | 220007933 | 1.74 | 0 | Curative (C) | 2013-08-13 | 2015-01-30 | Dasatinib | null | N | 220030366 | DASATINIB |
| 220017383 | 220007936 | 1.8 | 0 | Curative (C) | 2015-01-31 | 2015-01-31 | Dasatinib | Y | N | 220030379 | DASATINIB |
| 220017384 | 220007936 | 1.83 | 99 | Palliative (P) | 2014-11-14 | 2015-01-07 | AML18 PILOT TRIAL | N | N | 220030379 | PILOT TRIAL |